Pancreatic cancer trials in Spain

In Spain 86 Also abroad 1094

86 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 14 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
LuMIERE: A Phase 1/2, Multicenter, Open label, Non randomized Study to Investigate Safety and Tolerability, Pharmacokinetics, Dosimetry, and Preliminary Activity of [177Lu]Lu-FAP-2286 in Participants with an Advanced Solid Tumor
Where
A Coruña, Badalona, Madrid
Age
18 years and over
People
36 worldwide
Run by
Novartis Pharma AG
See details and how to joinNCT04939610 · EU 2023-508995-12-01
Phase 1/2Taking people
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Where
Badalona, Barcelona, Madrid, Málaga, Pamplona
Age
18 years and over
People
1,109 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT04895709
Phase 1Taking people
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
Where
Barcelona, Madrid
Age
18 years and over
People
434 worldwide
Run by
Amgen
See details and how to joinNCT07094113
Phase 1Taking people
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Where
Barcelona, Madrid
Age
18 years to 100 years
People
162 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06562192
Phase 1Taking people
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
Where
Barcelona, Madrid
Age
18 years and over
People
220 worldwide
Run by
MOMA Therapeutics
See details and how to joinNCT06545942
Phase 1Taking people
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Where
Barcelona, L'Hospitalet de Llobregat, Madrid
Age
18 years and over
People
714 worldwide
Run by
Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05208762 · EU 2023-506604-18-00
Phase 1Taking people
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Where
L'Hospitalet de Llobregat, Madrid
Age
18 years and over
People
914 worldwide
Run by
Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT06131840 · EU 2023-505858-18-00
Phase 1Taking people
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
Where
Barcelona, Madrid
Age
18 years and over
People
710 worldwide
Run by
Incyte Corporation
See details and how to joinNCT06179160 · EU 2023-507091-47-00
Phase 2Taking people
A Phase II trial of ginisortamab in participants with metastatic pancreatic ductal adenocarcinoma
Where
Barcelona, Madrid
Age
18 years and over
People
43 worldwide
Run by
Cancer Research UK
See details and how to join2024-514129-43-00
Phase 2/3Not yet taking people in Spain
A Study Comparing Whole-Body Heat Treatment Plus Systemic Therapy to Systemic Therapy Alone, for Advanced Pancreatic Cancer
Where
Madrid, Pamplona
Age
18 years and over
People
95 worldwide
Run by
ElmediX
See details and how to joinNCT07711067
No phaseEnrolling by invitation
Frequency of Care for Peripherally Inserted Central Vascular Access In the Prevention of Marsi
Where
Badalona
Age
18 years and over
People
150
Run by
Institut Català d'Oncologia
See details and how to joinNCT07697170
No phaseTaking people
The HistoSonics Edison™ System for Treatment of Pancreatic Adenocarcinoma Using Histotripsy
Where
Barcelona
Age
18 years and over
People
50
Run by
HistoSonics, Inc.
See details and how to joinNCT06282809
No phaseTaking people
Robotic vs Open Pancreatoduodenectomy
Where
Barcelona
Age
18 years and over
People
120
Run by
Hospital del Mar
See details and how to joinNCT06981273
Phase 1Taking people
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Where
Barcelona, Elche, Jerez de la Frontera, Madrid, Málaga, Santander
Age
18 years and over
People
1,006 worldwide
Run by
Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT04389632 · EU 2023-508469-34-00
Phase 2Taking people
A phase IIa, single-arm, single-center, open label, proof-of-concept trial evaluating increased frequency dosing of VCN-01 (zabilugene almadenorepvec) in combination with nab-Paclitaxel/Gemcitabine (GnP) in Patients with Newly-Diagnosed Metastatic Pancreatic Cancer (VIRAGE2)
Where
Madrid
Age
18 years and over
People
6
Run by
Theriva Biologics S.L.
See details and how to join2026-525566-21-00
Phase 1/2Taking people
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Where
Badalona, Hortaleza
Age
18 years and over
People
252 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07223047
Phase 2Not yet taking people in Spain
A Clinical Study Evaluating a New Treatment Strategy for Patients With Advanced Pancreatic Cancer Who Have Not Received Prior Treatment for Advanced Disease.
Where
Barcelona, Málaga, San Sebastián, Santander, Santiago de Compostela, Zaragoza
Age
18 years and over
People
40
Run by
Nelum Corp
See details and how to joinNCT07578337 · EU 2026-525796-90-00
Phase 1Taking people
Phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu]Lu-NNS309 in patients with pancreatic, lung, breast and colorectal cancers.
Where
Barcelona, Madrid
Age
18 years and over
People
76 worldwide
Run by
Novartis Pharma AG
See details and how to join2023-510356-23-00
Phase 2Taking people
Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients
Where
Barcelona, Córdoba, Madrid, Santiago de Compostela, Toledo
Age
18 years and over
People
240 worldwide
Run by
National Cancer Institute, Naples
See details and how to joinNCT05821556 · EU 2024-518710-11-00
No phaseNot yet taking people in Spain
Impact of Hypertrophy-oriented Resistance Training on Muscle Mass and Quality of Life in Patients With Unresectable Pancreatic Cancer
Where
Madrid
Age
18 years and over
People
10
Run by
Universidad Europea de Madrid
See details and how to joinNCT07470268
Phase 1Taking people
OMTX705-006 Phase 1b
Where
Barcelona, Donostia, L'Hospitalet de Llobregat, Madrid, Pamplona, Santiago de Compostela
Age
18 years and over
People
54
Run by
Oncomatryx Biopharma S.A.
See details and how to join2025-521872-69-00
No phaseNot yet taking people in Spain
Comparison of Transmesocolic Versus Retromesenteric Reconstruction in Cephalic Duodenopancreatectomy (FAST Trial)
Where
L'Hospitalet de Llobregat
Age
18 years and over
People
124
Run by
Hospital Universitari de Bellvitge
See details and how to joinNCT07368218
Phase 1Taking people
Sotorasib combined with first-line chemotherapy for advanced pancreatic adenocarcinoma
Where
Barcelona, Córdoba, Donostia, L'Hospitalet de Llobregat, Madrid, Málaga, Ourense, Oviedo, Pamplona, Salamanca, Santander, Valencia, Zaragoza
Age
18 years and over
People
15 worldwide
Run by
Asociacion Grupo Tratamiento De Tumores Digestivos
See details and how to join2024-516233-12-00
Phase 1/2Taking people
TTFields and Chemotherapy in Metastatic Pancreatic Adenocarcinoma (mPDAC)
Where
Barakaldo, Barcelona, Galdakao, Madrid, Pamplona, Vitoria
Age
18 years and over
People
30
Run by
Clinica Universidad de Navarra, Universidad de Navarra
See details and how to joinNCT07284277 · EU 2024-511459-16-00
Phase 1/2Taking people
Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI
Where
Barcelona
Age
18 years and over
People
126 worldwide
Run by
Maastricht University Medical Center
See details and how to joinNCT04954599